Prevalence and antimicrobial susceptibility pattern of Vibrio cholerae isolates from cholera outbreak sites in Ethiopia.
Humans
Cholera
/ epidemiology
Vibrio cholerae
/ isolation & purification
Ethiopia
/ epidemiology
Prevalence
Cross-Sectional Studies
Adult
Female
Adolescent
Disease Outbreaks
Male
Anti-Bacterial Agents
/ pharmacology
Young Adult
Feces
/ microbiology
Middle Aged
Microbial Sensitivity Tests
Child
Child, Preschool
Vibrio cholerae
Antimicrobials
Cholera outbreak
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
received:
23
01
2024
accepted:
29
07
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
31
7
2024
Statut:
epublish
Résumé
Cholera is an acute infectious disease caused by ingestion of contaminated food or water with Vibrio cholerae. Cholera remains a global threat to public health and an indicator of inequity and lack of social development. The aim of this study was to assess the prevalence and antimicrobial susceptibility pattern of V. cholerae from cholera outbreak sites in Ethiopia. Across-sectional study was conducted from May 2022 to October 2023 across different regions in Ethiopia: Oromia National Regional State, Amhara National Regional State and Addis Ababa City Administration. A total of 415 fecal samples were collected from the three regions. Two milliliter fecal samples were collected from each study participants. The collected samples were cultured on Blood Agar, MacConkey Agar and Thiosulfate Citrate Bile Salt Sucrose Agar. A series of biochemical tests Oxidase test, String test, Motility, Indole, Citrate, Gas production, H The prevalence of V. cholerae in the fecal samples was 30.1%. Majority of the isolates were from Oromia National Regional State 43.2% (n = 54) followed by Amhara National Regional State 31.2% (n = 39) and Addis Ababa City Administration 25.6% (n = 32). Most of the V. cholerae isolates were O1 serogroups 90.4% (n = 113) and Ogawa serotypes 86.4% (n = 108). Majority of the isolates were susceptible to ciprofloxacin 100% (n = 125), tetracycline 72% (n = 90) and gentamycin 68% (n = 85). More than half of the isolates were resistant to trimethoprim-sulfamethoxazole 62.4% (n = 78) and ampicillin 56.8% (n = 71). In this study, participants unable to read and write were about four times more at risk for V. cholerae infection (AOR: 3.8, 95% CI: 1.07-13.33). In addition, consumption of river water were about three times more at risk for V. cholerae infection (AOR: 2.8, 95% CI: 1.08-7.08). our study revealed a high prevalence of V. cholerae from fecal samples. The predominant serogroups and serotypes were O1 and Ogawa, respectively. Fortunately, the isolates showed susceptible to most tested antibiotics. Drinking water from river were the identified associated risk factor for V. cholerae infection. Protecting the community from drinking of river water and provision of safe and treated water could reduce cholera outbreaks in the study areas.
Sections du résumé
BACKGROUND
BACKGROUND
Cholera is an acute infectious disease caused by ingestion of contaminated food or water with Vibrio cholerae. Cholera remains a global threat to public health and an indicator of inequity and lack of social development. The aim of this study was to assess the prevalence and antimicrobial susceptibility pattern of V. cholerae from cholera outbreak sites in Ethiopia.
METHODS
METHODS
Across-sectional study was conducted from May 2022 to October 2023 across different regions in Ethiopia: Oromia National Regional State, Amhara National Regional State and Addis Ababa City Administration. A total of 415 fecal samples were collected from the three regions. Two milliliter fecal samples were collected from each study participants. The collected samples were cultured on Blood Agar, MacConkey Agar and Thiosulfate Citrate Bile Salt Sucrose Agar. A series of biochemical tests Oxidase test, String test, Motility, Indole, Citrate, Gas production, H
RESULTS
RESULTS
The prevalence of V. cholerae in the fecal samples was 30.1%. Majority of the isolates were from Oromia National Regional State 43.2% (n = 54) followed by Amhara National Regional State 31.2% (n = 39) and Addis Ababa City Administration 25.6% (n = 32). Most of the V. cholerae isolates were O1 serogroups 90.4% (n = 113) and Ogawa serotypes 86.4% (n = 108). Majority of the isolates were susceptible to ciprofloxacin 100% (n = 125), tetracycline 72% (n = 90) and gentamycin 68% (n = 85). More than half of the isolates were resistant to trimethoprim-sulfamethoxazole 62.4% (n = 78) and ampicillin 56.8% (n = 71). In this study, participants unable to read and write were about four times more at risk for V. cholerae infection (AOR: 3.8, 95% CI: 1.07-13.33). In addition, consumption of river water were about three times more at risk for V. cholerae infection (AOR: 2.8, 95% CI: 1.08-7.08).
CONCLUSION
CONCLUSIONS
our study revealed a high prevalence of V. cholerae from fecal samples. The predominant serogroups and serotypes were O1 and Ogawa, respectively. Fortunately, the isolates showed susceptible to most tested antibiotics. Drinking water from river were the identified associated risk factor for V. cholerae infection. Protecting the community from drinking of river water and provision of safe and treated water could reduce cholera outbreaks in the study areas.
Identifiants
pubmed: 39085873
doi: 10.1186/s12889-024-19621-4
pii: 10.1186/s12889-024-19621-4
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2071Informations de copyright
© 2024. The Author(s).
Références
Asumah MN, Padhi BK, Sinha A. Rising cases of cholera in Ethiopia: a need for sustainable wash practices? Int J Surg. 2023;109(3):608–9.
pubmed: 37093098
pmcid: 10389514
doi: 10.1097/JS9.0000000000000196
Adagbada AO, Adesida SA, Nwaokorie FO, Niemogha M-T, Coker AO. Cholera epidemiology in Nigeria: an overview. Pan Afr Med J. 2012;12:59.
pubmed: 22937199
pmcid: 3428179
Mutreja A, Kim DW, Thomson NR, Connor TR, Lee JH, Kariuki S, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011;477(7365):462–5.
pubmed: 21866102
pmcid: 3736323
doi: 10.1038/nature10392
Lekshmi N, Joseph I, Ramamurthy T, Thomas S. Changing facades of Vibrio cholerae: an enigma in the epidemiology of cholera. Indian J Med Res. 2018;147(2):133.
pubmed: 29806601
pmcid: 5991131
doi: 10.4103/ijmr.IJMR_280_17
Li Z, Pang B, Wang D, Li J, Xu J, Fang Y, et al. Expanding dynamics of the virulence-related gene variations in the toxigenic Vibrio cholerae serogroup O1. BMC Genomics. 2019;20:1–12.
Son MS, Megli CJ, Kovacikova G, Qadri F, Taylor RK. Characterization of Vibrio cholerae O1 El Tor biotype variant clinical isolates from Bangladesh and Haiti, including a molecular genetic analysis of virulence genes. J Clin Microbiol. 2011;49(11):3739–49.
pubmed: 21880975
pmcid: 3209127
doi: 10.1128/JCM.01286-11
Waha K, Krummenauer L, Adams S, Aich V, Baarsch F, Coumou D, et al. Climate change impacts in the Middle East and Northern Africa (MENA) region and their implications for vulnerable population groups. Reg Envriron Chang. 2017;17(6):1623–38.
doi: 10.1007/s10113-017-1144-2
Stein R, Chirilã M. Routes of transmission in the food chain. Foodborne diseases. Third edition: Elsevier; 2017. pp. 65–103.
doi: 10.1016/B978-0-12-385007-2.00003-6
Usmani M, Brumfield KD, Jamal Y, Huq A, Colwell RR, Jutla A. A review of the environmental trigger and transmission components for prediction of cholera. Trop Med Infect Disease. 2021;6(3):147.
doi: 10.3390/tropicalmed6030147
Islam MS, Zaman M, Islam MS, Ahmed N, Clemens J. Environmental reservoirs of Vibrio cholerae. Vaccine. 2020;38:A52–62.
pubmed: 31285087
doi: 10.1016/j.vaccine.2019.06.033
Gwenzi W, Sanganyado E. Recurrent cholera outbreaks in Sub-saharan Africa: moving beyond epidemiology to understand the environmental reservoirs and drivers. Challenges. 2019;10(1):1.
doi: 10.3390/challe10010001
Vezzulli L, Pruzzo C, Huq A, Colwell RR. Environmental reservoirs of Vibrio cholerae and their role in cholera. Environ Microbiol Rep. 2010;2(1):27–33.
pubmed: 23765995
doi: 10.1111/j.1758-2229.2009.00128.x
Jubair M, Atanasova KR, Rahman M, Klose KE, Yasmin M, Yilmaz Ö, et al. Vibrio cholerae persisted in microcosm for 700 days inhibits motility but promotes biofilm formation in nutrient-poor lake water microcosms. PLoS ONE. 2014;9(3):e92883.
pubmed: 24667909
pmcid: 3965490
doi: 10.1371/journal.pone.0092883
Khan MD, Thi Vu HH, Lai QT, Ahn JW. Aggravation of human diseases and climate change nexus. Int J Environ Res Public Health. 2019;16(15):2799.
pubmed: 31390751
pmcid: 6696070
doi: 10.3390/ijerph16152799
Domman D, Chowdhury F, Khan AI, Dorman MJ, Mutreja A, Uddin MI, et al. Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh. Nat Genet. 2018;50(7):951–5.
pubmed: 29942084
pmcid: 6283067
doi: 10.1038/s41588-018-0150-8
Jutla A, Whitcombe E, Hasan N, Haley B, Akanda A, Huq A, et al. Environmental factors influencing epidemic cholera. Am J Trop Med Hyg. 2013;89(3):597.
pubmed: 23897993
pmcid: 3771306
doi: 10.4269/ajtmh.12-0721
Rebaudet S, Sudre B, Faucher B, Piarroux R. Environmental determinants of cholera outbreaks in inland Africa: a systematic review of main transmission foci and propagation routes. J Infect Dis. 2013;208(suppl1):S46–54.
pubmed: 24101645
doi: 10.1093/infdis/jit195
Jamison DT. Disease control priorities: improving health and reducing poverty. Lancet. 2018;391(10125):e11–4.
pubmed: 25662416
doi: 10.1016/S0140-6736(15)60097-6
Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9(6):e0003832.
pubmed: 26043000
pmcid: 4455997
doi: 10.1371/journal.pntd.0003832
Ali M, Lopez AL, You Y, Kim YE, Sah B, Maskery B, et al. The global burden of cholera. Bull World Health Organ. 2012;90:209–18.
pubmed: 22461716
pmcid: 3314202
doi: 10.2471/BLT.11.093427
Shannon K, Hast M, Azman AS, Legros D, McKay H, Lessler J. Cholera prevention and control in refugee settings: successes and continued challenges. PLoS Negl Trop Dis. 2019;13(6):e0007347.
pubmed: 31220084
pmcid: 6586254
doi: 10.1371/journal.pntd.0007347
Pankhurst R. The history of cholera in Ethiopia. Med Hist. 1968;12(3):262–9.
pubmed: 4875613
pmcid: 1033828
doi: 10.1017/S0025727300013302
Scrascia M, Pugliese N, Maimone F, Mohamud KA, Ali IA, Grimont PA, et al. Cholera in Ethiopia in the 1990s: epidemiologic patterns, clonal analysis, and antimicrobial resistance. Int J Med Microbiol. 2009;299(5):367–72.
pubmed: 19121605
doi: 10.1016/j.ijmm.2008.10.004
Hiruy AM, Mohammed J, Haileselassie MM, Acharya K, Butte G, Haile AT, et al. Spatiotemporal variation in urban wastewater pollution impacts on river microbiomes and associated hazards in the Akaki catchment, Addis Ababa, Ethiopia. Sci Total Environ. 2022;826:153912.
pubmed: 35183630
doi: 10.1016/j.scitotenv.2022.153912
Erkyihun GA, Asamene N, Woldegiorgis AZ. The threat of Cholera in Africa. Zoonoses. 2023;3(1):20230027.
doi: 10.15212/ZOONOSES-2023-0027
Chowdhury G, Senapati T, Das B, Kamath A, Pal D, Bose P, et al. Laboratory evaluation of the rapid diagnostic tests for the detection of Vibrio cholerae O1 using diarrheal samples. PLoS Negl Trop Dis. 2021;15(6):e0009521.
pubmed: 34129602
pmcid: 8232436
doi: 10.1371/journal.pntd.0009521
Islam MT, Khan AI, Sayeed MA, Amin J, Islam K, Alam N, et al. Field evaluation of a locally produced rapid diagnostic test for early detection of cholera in Bangladesh. PLoS Negl Trop Dis. 2019;13(1):e0007124.
pubmed: 30703097
pmcid: 6372204
doi: 10.1371/journal.pntd.0007124
Bonnin-Jusserand M, Copin S, Le Bris C, Brauge T, Gay M, Brisabois A, et al. Vibrio species involved in seafood-borne outbreaks (Vibrio cholerae, V. Parahaemolyticus and V. Vulnificus): review of microbiological versus recent molecular detection methods in seafood products. Crit Rev Food Sci Nutr. 2019;59(4):597–610.
pubmed: 28956623
doi: 10.1080/10408398.2017.1384715
SHNAWA IM. SEROLOGY OF VIBRIO CHOLERAE:. Hillah University College: Babylon, IRAQ; 2021. p. 18.
Jorgensen JH, Hindler JF, Reller LB, Weinstein MP. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis. 2007;44(2):280–6.
pubmed: 17173232
doi: 10.1086/510431
Safa A, Nair GB, Kong RY. Evolution of new variants of Vibrio cholerae O1. Trends Microbiol. 2010;18(1):46–54.
pubmed: 19942436
doi: 10.1016/j.tim.2009.10.003
Mengel MA, Delrieu I, Heyerdahl L, Gessner BD. Cholera outbreaks in Africa. Cholera outbreaks; 2014. pp. 117–44.
Park SE, Jeon Y, Kang S, Gedefaw A, Hailu D, Yeshitela B, et al. Infectious disease control and management in Ethiopia: a case study of cholera. Front Public Health. 2022;10:870276.
pubmed: 35712321
pmcid: 9197421
doi: 10.3389/fpubh.2022.870276
Feyisa GC, Hailu T, Beyene Z. Acute watery diarrhea outbreak investigation in Raya Kobbo district, Amahara region of Ethiopia-consequence of drought and poor sanitation: a case-control study. J Health Med Nurs. 2017;1(2):44–59.
Mohammed A, Zungu L, Hoque M. Access to safe drinking water and availability of environmental sanitation facilities among Dukem town households in Ethiopia. J Hum Ecol. 2013;41(2):131–8.
doi: 10.1080/09709274.2013.11906560
Challa JM, Getachew T, Debella A, Merid M, Atnafe G, Eyeberu A, et al. Inadequate hand washing, lack of clean drinking water and latrines as major determinants of cholera outbreak in Somali region, Ethiopia in 2019. Front Public Health. 2022;10:845057.
pubmed: 35602140
pmcid: 9120658
doi: 10.3389/fpubh.2022.845057
Parvin I, Shahunja K, Khan SH, Alam T, Shahrin L, Ackhter MM, et al. Changing susceptibility pattern of Vibrio cholerae O1 isolates to commonly used antibiotics in the largest diarrheal disease hospital in Bangladesh during 2000–2018. Am J Trop Med Hyg. 2020;103(2):652.
pubmed: 32458788
pmcid: 7410410
doi: 10.4269/ajtmh.20-0058
Zahid QUA, Khursheed N, Adnan F, Zafar A. Cholera Outbreak 2022 in Karachi: a Report on Serotype and Antibiotic Susceptibility Pattern. J Coll Physicians Surgeons–pakistan: JCPSP. 2022;32(12):1613–6.
doi: 10.29271/jcpsp.2022.12.1613
Junejo S, Shahid S, Khursheed N, Maqsood S, Adnan F, Khalid F. Cholera outbreak in 2022 among children in Karachi: study of cases attending to a Tertiary Care Hospital. Pakistan J Med Sci. 2023;39(5):1496.
Marin MA, Thompson CC, Freitas FS, Fonseca EL, Aboderin AO, Zailani SB, et al. Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae. PLoS Negl Trop Dis. 2013;7(2):e2049.
pubmed: 23459673
pmcid: 3573102
doi: 10.1371/journal.pntd.0002049
Islam MS, Drasar BS, Sack RB. Probable role of blue-green algae in maintaining endemicity and seasonality of cholera in Bangladesh: a hypothesis. J Diarrhoeal Dis Res. 1994;12(4):245–56.
pubmed: 7751564
Zo Y-G, Rivera IN, Russek-Cohen E, Islam MS, Siddique A, Yunus M et al. Genomic profiles of clinical and environmental isolates of Vibrio cholerae O1 in cholera-endemic areas of Bangladesh. Proceedings of the National Academy of Sciences. 2002;99(19):12409-14.
Emch M, Feldacker C, Islam MS, Ali M. Seasonality of cholera from 1974 to 2005: a review of global patterns. Int J Health Geogr. 2008;7(1):1–13.
doi: 10.1186/1476-072X-7-31
Alam M, Hasan NA, Sadique A, Bhuiyan N, Ahmed KU, Nusrin S, et al. Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh. Appl Environ Microbiol. 2006;72(6):4096–104.
pubmed: 16751520
pmcid: 1489596
doi: 10.1128/AEM.00066-06
Baddam R, Sarker N, Ahmed D, Mazumder R, Abdullah A, Morshed R, et al. Genome dynamics of Vibrio cholerae isolates linked to seasonal outbreaks of cholera in Dhaka. Bangladesh MBio. 2020;11(1):03339–19.
Islam MT, Alam M, Boucher Y. Emergence, ecology and dispersal of the pandemic generating Vibrio cholerae lineage. Int Microbiol. 2017;20(3):106–15.
pubmed: 29446801
Hounmanou YMG, Mdegela RH, Dougnon TV, Madsen H, Withey JH, Olsen JE, et al. Tilapia (Oreochromis niloticus) as a putative reservoir host for survival and transmission of Vibrio cholerae O1 biotype El Tor in the aquatic environment. Front Microbiol. 2019;10:1215.
pubmed: 31214149
pmcid: 6554700
doi: 10.3389/fmicb.2019.01215
Yuan X-h, Li Y-m, Vaziri AZ, Kaviar VH, Jin Y, Jin Y, et al. Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2022;11(1):62.
pubmed: 35468830
pmcid: 9036709
doi: 10.1186/s13756-022-01100-3
Shah MM, Bundi M, Kathiiko C, Guyo S, Galata A, Miringu G, et al. Antibiotic-Resistant Vibrio cholerae O1 and its SXT Elements Associated with two Cholera epidemics in Kenya in 2007 to 2010 and 2015 to 2016. Microbiol Spectr. 2023;11(3):e04140–22.
pubmed: 37125926
pmcid: 10269778
doi: 10.1128/spectrum.04140-22
Mohammed Y, Aboderin AO, Okeke IN, Olayinka AT. Antimicrobial resistance of Vibrio cholerae from Sub-saharan Africa: a systematic review. Afr J Lab Med. 2018;7(2):1–7.
doi: 10.4102/ajlm.v7i2.778
Abioye OE, Nontongana N, Osunla CA, Okoh AI. Antibiotic resistance and virulence genes profiling of Vibrio cholerae and Vibrio mimicus isolates from some seafood collected at the aquatic environment and wet markets in Eastern Cape Province, South Africa. PLoS ONE. 2023;18(8):e0290356.
pubmed: 37616193
pmcid: 10449182
doi: 10.1371/journal.pone.0290356
Abera B, Bezabih B, Dessie A. Antimicrobial suceptibility of V. Cholerae in North West, Ethiopia. Ethiop Med J. 2010;48(1):23–8.
pubmed: 20607994
Newman MJ, Mensah P, Adjei O, Asamoah-Adu A, Adu-Sarkodie Y, Apeagyei F. Antibiotic susceptibility patterns of Vibrio cholerae isolates in Ghana. Ghana Med J. 2004;38(2):72–4.
Danso EK, Asare P, Otchere ID, Akyeh LM, Asante-Poku A, Aboagye SY, et al. A molecular and epidemiological study of Vibrio cholerae isolates from cholera outbreaks in southern Ghana. PLoS ONE. 2020;15(7):e0236016.
pubmed: 32649692
pmcid: 7351161
doi: 10.1371/journal.pone.0236016
Tang KWK, Millar BC, Moore JE. Antimicrobial resistance (AMR). Br J Biomed Sci. 2023;80:11387.
pubmed: 37448857
pmcid: 10336207
doi: 10.3389/bjbs.2023.11387
Shallcross LJ, Davies SC. The World Health Assembly resolution on antimicrobial resistance. J Antimicrob Chemother. 2014;69(11):2883–5.
pubmed: 25204342
doi: 10.1093/jac/dku346
Richterman A, Sainvilien DR, Eberly L, Ivers LC. Individual and household risk factors for symptomatic cholera infection: a systematic review and meta-analysis. J Infect Dis. 2018;218(3):S154–64.
pubmed: 30137536
pmcid: 6188541
doi: 10.1093/infdis/jiy444
Shackleton D, Memon FA, Nichols G, Phalkey R, Chen AS. Mechanisms of cholera transmission via environment in India and Bangladesh: state of the science review. Rev Environ Health. 2024;39(2):313–29.
pubmed: 36639850
doi: 10.1515/reveh-2022-0201
Gaffga NH, Tauxe RV, Mintz ED. Cholera: a new homeland in Africa? Am J Trop Med Hyg. 2007;77(4):705.
pubmed: 17978075
doi: 10.4269/ajtmh.2007.77.705
Chowdhury F, Ross AG, Islam MT, McMillan NA, Qadri F. Diagnosis, management, and future control of cholera. Clin Microbiol Rev. 2022;35(3):e00211–21.
pubmed: 35726607
pmcid: 9491185
doi: 10.1128/cmr.00211-21